This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia

Article Abstract

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Kane et al., in their recent (January 2005) CME activity"Optimizing Pharmacotherapy to Maximize Outcome inSchizophrenia,"1 recommend using a long-acting depot injectionin patients who fail to adhere to antipsychotic treatment.While depot medications ensure compliance, they may not fostercertain aspects of the doctor-patient relationship, and evenwith depot medication, about 25% of patients stop keepingscheduled appointments and no longer receive depot injectionswithin 1 year after starting treatment.2 Furthermore, depotmedications may be associated with an increased risk for prolongedside effects.3‘ ‹


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 66

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders